SPIA
NKTR icon

Steward Partners Investment Advisory’s Nektar Therapeutics NKTR Stock Holding History

Steward Partners Investment Advisory’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
15,526
+15,313
+7,189% +$872K 0.01% 1111
2025
Q4 		$9.01K Hold
213
– – ﹤0.01% 3484
2025
Q3 		$12.1K Buy
213
+211
+10,550% +$6.98K ﹤0.01% 3322
2025
Q2 		$52 Sell
2
-1
-33% -$11 ﹤0.01% 4062
2025
Q1 		$27 Hold
3
– – ﹤0.01% 3981
2024
Q4 		$37 Hold
3
– – ﹤0.01% 3938
2024
Q3 		$52 Hold
3
– – ﹤0.01% 3689
2024
Q2 		$50 Sell
3
-10
-77% -$211 ﹤0.01% 3572
2024
Q1 		$187 Hold
13
– – ﹤0.01% 3476
2023
Q4 		$113 Hold
13
– – ﹤0.01% 3435
2023
Q3 		$119 Hold
13
– – ﹤0.01% 3316
2023
Q2 		$115 Hold
13
– – ﹤0.01% 3263
2023
Q1 		$141 Hold
13
– – ﹤0.01% 3243
2022
Q4 		$452 Hold
13
– – ﹤0.01% 3205
2022
Q3 		$1K Buy
+13
New +$773 ﹤0.01% 3143
2022
Q2 		– Sell
-129
Closed -$10K – 3325
2022
Q1 		$10K Hold
129
– – ﹤0.01% 2667
2021
Q4 		$26K Hold
129
– – ﹤0.01% 2214
2021
Q3 		$35K Sell
129
-33
-20% -$7.93K ﹤0.01% 2054
2021
Q2 		$42K Buy
+162
New +$44.8K ﹤0.01% 3686
2020
Q1 		– Sell
-40
Closed -$12K – 2629
2019
Q4 		$12K Hold
40
– – ﹤0.01% 1955
2019
Q3 		$10K Buy
+40
New +$14.7K ﹤0.01% 1995

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Steward Partners Investment Advisory's NKTR Position: Q1 2026 in Review

Steward Partners Investment Advisory increased its Nektar Therapeutics (NKTR) stake by 7,189% in Q1 2026, buying an estimated $872K and bringing the position to 15,526 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1111.

Steward Partners Investment Advisory first reported a position in NKTR in Q3 2019 and has held it in 21 quarters since. 215 funds tracked by Wall St. Rank hold NKTR as of Q1 2026.

  • Steward Partners Investment Advisory held 15,526 shares of Nektar Therapeutics worth $1.12M as of Q1 2026.
  • Steward Partners Investment Advisory bought 15,313 Nektar Therapeutics shares in Q1 2026, an estimated $872K.
  • Nektar Therapeutics made up 0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #1111 holding.
  • Steward Partners Investment Advisory first reported a position in Nektar Therapeutics in Q3 2019 and has held it in 21 quarters since.
  • 215 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.